Cerebral edema
Adult: 10 mg (phosphate) IV, then 4 mg IM q 6 h 2-4 day, then taper over 5-7 day.
Inflammatory conditions, allergic reactions, neoplasias
Child: 0.024-0.34 mg/kg PO qd in 4 divided doses.
Adult: 0.75-9 mg (acetate) PO qd divided bid, tid or qid. 4-16 mg intra-articularly or into soft tissue q 1-3 wk; 0.8-1.6 mg into lesions q 1-3 wk; or 8-16 mg (phosphate) IM q 1-3 wk prn. Or 0.2-6 mg (phosphate) intra-articularly, intralesionally, or into soft tissue; or 0.5-9 mg (phosphate) IM.
Shock (other than adrenal crisis)
Adult: 1-6 mg/kg (phosphate) IV qd as single dose; or 40 mg IV q 2-6 h prn, for max of 48-72 h.
Dexamethasone suppression test for Cushings syndrome
Adult: 0.5 mg PO q 6 h × 48 h.
Adrenal insufficiency
Child: 0.024-0.34 mg/kg PO qd in 4 divided doses.
Adult: 0.75-9 mg PO qd in divided doses.
Child: 0.235-1.25 mg/m2 (phosphate) IM or IV once/day or bid.
Adult: 0.5-9 mg (phosphate) IM or IV qd.
Bacterial meningitis
Infant, child > 2 month, adult: 0.15 mg/kg (phosphate) IV q 6 h × 2-4 day.
Prevention of hyaline membrane disease in premature infant
Adult: 5 mg (phosphate) IM tid to mother × 2 day before delivery.
Prevention of CA chemotherapy
induced nausea and vomiting-Adult: 10-20 mg IV before chemotherapy. Additional doses given IV or PO 24-72 h after CA, chemotherapy prn. |